Myricetin Possesses Potential Protective Effects on Diabetic Cardiomyopathy through Inhibiting IκBα/NFκB and Enhancing Nrf2/HO-1

Diabetic cardiomyopathy (DCM) is associated with a greater risk of mortality in patients with diabetes mellitus. Currently, no specific treatment has been suggested for DCM treatment. This study demonstrated that myricetin (M) attenuated DCM-associated cardiac injury in mice subjected to streptozoto...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oxid Med Cell Longev
Huvudupphovsmän: Liao, Hai-han, Zhu, Jin-xiu, Feng, Hong, Ni, Jian, Zhang, Nan, Chen, Si, Liu, Huang-jun, Yang, Zheng, Deng, Wei, Tang, Qi-Zhu
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi 2017
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5632894/
https://ncbi.nlm.nih.gov/pubmed/29147465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/8370593
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk